Regulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding

Hiroaki Mita1, Junichiro Tsutsui, Mutsuhiro Takekawa

  • 1Dana-Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.

Insights

Cellular stress activates p38 and JNK pathways via MTK1. GADD45 proteins bind MTK1, relieving autoinhibition and activating downstream kinases for stress response.

Area of Science:

  • Cellular biology
  • Molecular signaling
  • Stress response pathways

Background:

  • Cellular stresses activate stress-responsive mitogen-activated protein (MAP) kinases, including p38 and JNK.
  • MTK1 (MEKK4) is a MAP kinase kinase kinase that mediates the activation of both p38 and JNK pathways.

Purpose of the Study:

  • To elucidate the activation mechanism of the human MAP kinase kinase kinase, MTK1.
  • To identify factors that regulate MTK1 activity in cellular stress responses.

Main Methods:

  • Functional complementation screening in yeast cells to identify MTK1 activators.
  • Site-directed mutagenesis to generate constitutively active MTK1 mutants.
  • Analysis of MTK1 kinase activity and substrate interaction (MKK6) in yeast and mammalian cells.

Main Results:

  • MTK1 possesses an autoinhibitory domain (residues 253-553) in its N-terminal noncatalytic region, rendering it inactive in full-length form.
  • GADD45 proteins (alpha, beta, gamma) were identified as novel MTK1 activators that bind near the inhibitory domain and relieve autoinhibition.
  • Constitutively active MTK1 mutants were generated, capable of interacting with MKK6 independently of GADD45 binding.

Conclusions:

  • MTK1 activity is regulated by autoinhibition mediated by its N-terminal domain.
  • GADD45 proteins play a crucial role in MTK1 activation, linking cellular stress signals to p38 and JNK pathways.
  • Understanding MTK1 regulation provides insights into stress signaling and potential therapeutic targets.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...